Intracellular Aβ and its Pathological Role in Alzheimer’s Disease: Lessons from Cellular to Animal Models

Author(s): Lina Ji, Xi Zhao, Weijie Lu, Qing Zhang, Zichun Hua

Journal Name: Current Alzheimer Research

Volume 13 , Issue 6 , 2016

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor


Accumulation of intraneuronal amyloid-β peptide (Aβ) appears to be an early event in Alzheimer's disease (AD), suggesting its important role in the neurodegenerative process of AD. It is indicated that intracellular Aβ originates from a portion of Aβ, which is not secreted and consequently remains intracellular, or alternatively from the secreted Aβ, which is internalized into intracellular Aβ pool. A number of cell and transgenic animal models are established to study the pathological role of intracellular Aβ, and to screen for drugs against Aβ aggregation and associated toxicity. Aβ aggregates, particularly oligomers, may lead to synaptic dysfunction and neuronal loss. Screened from high-throughput methods, a number of cellpermeable agents reduce the aggregation of intracellular Aβ and antagonize its cytotoxicity by inhibiting the formation of Aβ oligomers in vivo. The multi-functional roles of Aβ in alternate pathways and associated clinical implications for AD treatment are also discussed.

Keywords: Alzheimer’s disease, aggregation, animal models, cell models, intracellular Aβ, oligomers, neurotoxicity, synaptic dysfunction.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Published on: 14 April, 2016
Page: [621 - 630]
Pages: 10
DOI: 10.2174/1567205013666160322142226
Price: $65

Article Metrics

PDF: 46
PRC: 1